CXCR5+CD8 T cell infiltration of hepatocellular carcinomas generate a robust anti-tumor response in association with B cell antibody production, through IL-21 production, that correlates with a reduction in early tumor recurrence, and is not associated with peritumoral liver or blood tissues (29). This evidence concerns the gene CXCR5 and hepatocellular carcinoma.